GLP-1 medications slow gastric emptying, which can cause nausea, constipation, and bloating
Men in those trials lost weight consistently, with results varying by starting weight, diet, and adherence
The Phase 2 trials enrolled people with a BMI of 27 or higher with at least one weight-related condition, or a BMI of 30 or higher without additional conditions
Gut-Brain Connection Emerging science suggests GLP-1s may enhance gut motility, microbial diversity, and hormone signalingkey elements in mood, cognition, and immune response
Semaglutide (Ozempic para diabetes, Wegovy para manejo de peso) es un agonista selectivo del receptor GLP-1 que ha demostrado eficacia robusta en ensayos clnicos
During the quiz, youll answer questions about where youre currently at in your journey (height, weight), what your goals are, and some other personal questions